Literature DB >> 24549919

[Which kind of structures and facilities are needed for the care of elderly patients with rheumatic diseases?].

C Fiehn1.   

Abstract

In the coming years the number of elderly patients with rheumatic diseases in Germany will continuously increase. Therefore, it is necessary that the structures of the healthcare system for elderly patients with rheumatic diseases are prepared for this challenge. Two important fields are of particular relevance: multimorbidity and the prevention of disability. Both points do not only affect elderly patients but are particularly important in this group. In order to solve the problems structures which facilitate interdisciplinary care should be supported. Moreover, institutions which provide rehabilitation should be utilized for the care of elderly patients with rheumatic diseases. Both can be performed in either outpatient or inpatient settings. Rheumatologists working in interdisciplinary fields, in outpatient practices, and in specialized rheumatology hospitals have key functions in the care of elderly patients with rheumatic diseases. However, practices and hospitals both have to solve the special problems of reimbursement and interfaces between the sectors.

Entities:  

Keywords:  Age; Comorbidity; Delivery of health care; Rehabilitation; Rheumatoid arthritis

Mesh:

Year:  2014        PMID: 24549919     DOI: 10.1007/s00393-013-1242-6

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  20 in total

1.  2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.

Authors:  Daniel Aletaha; Tuhina Neogi; Alan J Silman; Julia Funovits; David T Felson; Clifton O Bingham; Neal S Birnbaum; Gerd R Burmester; Vivian P Bykerk; Marc D Cohen; Bernard Combe; Karen H Costenbader; Maxime Dougados; Paul Emery; Gianfranco Ferraccioli; Johanna M W Hazes; Kathryn Hobbs; Tom W J Huizinga; Arthur Kavanaugh; Jonathan Kay; Tore K Kvien; Timothy Laing; Philip Mease; Henri A Ménard; Larry W Moreland; Raymond L Naden; Theodore Pincus; Josef S Smolen; Ewa Stanislawska-Biernat; Deborah Symmons; Paul P Tak; Katherine S Upchurch; Jirí Vencovsky; Frederick Wolfe; Gillian Hawker
Journal:  Ann Rheum Dis       Date:  2010-09       Impact factor: 19.103

2.  Efficacy of total joint arthroplasty in patients with established rheumatoid arthritis: improved longitudinal effects on disease activity but not on health-related quality of life.

Authors:  Shigeki Momohara; Eisuke Inoue; Katsunori Ikari; Koichiro Yano; Asami Tokita; Taku Suzuki; Yu Sakuma; Ryo Hiroshima; Kosei Kawakami; Ikuko Masuda; Takuji Iwamoto; Atsuo Taniguchi; Hisashi Yamanaka
Journal:  Mod Rheumatol       Date:  2011-03-04       Impact factor: 3.023

3.  Rheumatoid arthritis and falls: the influence of disease activity.

Authors:  Christoph Böhler; Helga Radner; Michaela Ernst; Alexa Binder; Tanja Stamm; Daniel Aletaha; Josef S Smolen; Marcus Köller
Journal:  Rheumatology (Oxford)       Date:  2012-08-09       Impact factor: 7.580

4.  [Comorbidity in rheumatoid arthritis of early onset. Effects on outcome parameters].

Authors:  G Westhoff; C Weber; A Zink
Journal:  Z Rheumatol       Date:  2006-10       Impact factor: 1.372

5.  Does the age of onset of rheumatoid arthritis influence phenotype?: a prospective study of outcome and prognostic factors.

Authors:  C T Pease; B B Bhakta; J Devlin; P Emery
Journal:  Rheumatology (Oxford)       Date:  1999-03       Impact factor: 7.580

6.  The risk of myocardial infarction in rheumatoid arthritis and diabetes mellitus: a Danish nationwide cohort study.

Authors:  Jesper Lindhardsen; Ole Ahlehoff; Gunnar Hilmar Gislason; Ole Rintek Madsen; Jonas Bjerring Olesen; Christian Torp-Pedersen; Peter Riis Hansen
Journal:  Ann Rheum Dis       Date:  2011-03-09       Impact factor: 19.103

7.  [Multimorbidity in elderly rheumatic patients part 2].

Authors:  H-J Lakomek; T Brabant; M Lakomek; D Lüttje
Journal:  Z Rheumatol       Date:  2013-08       Impact factor: 1.372

8.  [Multimorbidity in elderly rheumatic patients part 1].

Authors:  H-J Lakomek; T Brabant; M Lakomek; D Lüttje
Journal:  Z Rheumatol       Date:  2013-08       Impact factor: 1.372

9.  Safety and efficacy of etanercept treatment in elderly subjects with rheumatoid arthritis.

Authors:  Joan M Bathon; Roy M Fleischmann; Désirée Van der Heijde; John R Tesser; Paul M Peloso; Yun Chon; Barbara White
Journal:  J Rheumatol       Date:  2006-02       Impact factor: 4.666

10.  The incidence of rheumatoid arthritis in the UK: comparisons using the 2010 ACR/EULAR classification criteria and the 1987 ACR classification criteria. Results from the Norfolk Arthritis Register.

Authors:  Jennifer H Humphreys; Suzanne M M Verstappen; Kimme L Hyrich; Jacqueline R Chipping; Tarnya Marshall; Deborah P M Symmons
Journal:  Ann Rheum Dis       Date:  2012-09-03       Impact factor: 19.103

View more
  2 in total

Review 1.  [Characteristics of pharmacotherapy in older patients with rheumatism].

Authors:  H-J Lakomek; Christian Schulz
Journal:  Z Rheumatol       Date:  2018-06       Impact factor: 1.372

Review 2.  [Complex treatments in rheumatology and geriatrics - Challenges - Differences - Chances].

Authors:  H-J Lakomek; W Fiori
Journal:  Z Rheumatol       Date:  2018-06       Impact factor: 1.372

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.